-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, AlldbfkjJlKj3Ua0Shn+CpoLp3HhThlkn5VdzLr0OggNZibRgde8GfKDbWbzlun7 dtgH645vHKthGN3tKMYHiQ== 0001209191-06-065297.txt : 20061215 0001209191-06-065297.hdr.sgml : 20061215 20061215173132 ACCESSION NUMBER: 0001209191-06-065297 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20061213 FILED AS OF DATE: 20061215 DATE AS OF CHANGE: 20061215 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SANGAMO BIOSCIENCES INC CENTRAL INDEX KEY: 0001001233 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 680359556 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 501 CANAL BLVD STREET 2: SUITE A100 CITY: RICHMOND STATE: CA ZIP: 94804 BUSINESS PHONE: 5109706000 MAIL ADDRESS: STREET 1: 501 CANAL BLVD STREET 2: SUITE A100 CITY: RICHMOND STATE: CA ZIP: 94804 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LANPHIER EDWARD O II CENTRAL INDEX KEY: 0001234386 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-30171 FILM NUMBER: 061281520 BUSINESS ADDRESS: BUSINESS PHONE: 415-442-1429 MAIL ADDRESS: STREET 1: C/O SANGAMO BIOSCIENCES IN STE.A-100 STREET 2: POINT RICHMOND TECH CENTER 501 CANA BLVD CITY: RICHMOND STATE: CA ZIP: 94804 4 1 bsf25900_bsf5el.xml MAIN DOCUMENT DESCRIPTION X0202 4 2006-12-13 0001001233 SANGAMO BIOSCIENCES INC SGMO 0001234386 LANPHIER EDWARD O II C/O SANGAMO BIOSCIENCES, INC. STE: 100A POINT RICHMOND TECH CNTR, 501 CANAL BL RICHMOND CA 94804 1 1 0 0 President & CEO Employee Stock Option Right to Buy 6.82 2006-12-13 4 A 0 200000 0 A 2016-12-13 Common Stock 200000 200000 D The stock options vest and become exercisable for twenty five percent of the shares upon the optionee's completion of one year of service measured from the grant date and vest and become exercisable for the balance of the shares in thirty six successive equal monthly installments upon his or her completion of each additional month of service thereafter. The options will vest on an accelerated basis, whether or not the company is assumed or replaced by an acquiring entity. /s/Edward O. Lanphier II 2006-12-15 -----END PRIVACY-ENHANCED MESSAGE-----